These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 11179134)

  • 1. Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis.
    Seymour JF; Presneill JJ; Schoch OD; Downie GH; Moore PE; Doyle IR; Vincent JM; Nakata K; Kitamura T; Langton D; Pain MC; Dunn AR
    Am J Respir Crit Care Med; 2001 Feb; 163(2):524-31. PubMed ID: 11179134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis.
    Wylam ME; Ten R; Prakash UB; Nadrous HF; Clawson ML; Anderson PM
    Eur Respir J; 2006 Mar; 27(3):585-93. PubMed ID: 16507860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled GM-CSF for Pulmonary Alveolar Proteinosis.
    Tazawa R; Ueda T; Abe M; Tatsumi K; Eda R; Kondoh S; Morimoto K; Tanaka T; Yamaguchi E; Takahashi A; Oda M; Ishii H; Izumi S; Sugiyama H; Nakagawa A; Tomii K; Suzuki M; Konno S; Ohkouchi S; Tode N; Handa T; Hirai T; Inoue Y; Arai T; Asakawa K; Sakagami T; Hashimoto A; Tanaka T; Takada T; Mikami A; Kitamura N; Nakata K
    N Engl J Med; 2019 Sep; 381(10):923-932. PubMed ID: 31483963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis.
    Kavuru MS; Sullivan EJ; Piccin R; Thomassen MJ; Stoller JK
    Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1143-8. PubMed ID: 10764303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis.
    Bonfield TL; Russell D; Burgess S; Malur A; Kavuru MS; Thomassen MJ
    Am J Respir Cell Mol Biol; 2002 Oct; 27(4):481-6. PubMed ID: 12356582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte-macrophage colony-stimulating factor inhalation therapy for patients with idiopathic pulmonary alveolar proteinosis: a pilot study; and long-term treatment with aerosolized granulocyte-macrophage colony-stimulating factor: a case report.
    Tazawa R; Nakata K; Inoue Y; Nukiwa T
    Respirology; 2006 Jan; 11 Suppl():S61-4. PubMed ID: 16423274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Response to inhaled granulocyte-macrophage colony-stimulating factor in a patient with alveolar proteinosis].
    Rodríguez Portal JA; Rodríguez Becerra E; Sánchez Garrido A
    Arch Bronconeumol; 2009 Mar; 45(3):150-2. PubMed ID: 19286115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum neutralizing capacity of GM-CSF reflects disease severity in a patient with pulmonary alveolar proteinosis successfully treated with inhaled GM-CSF.
    Arai T; Hamano E; Inoue Y; Ryushi T; Nukiwa T; Sakatani M; Nakata K
    Respir Med; 2004 Dec; 98(12):1227-30. PubMed ID: 15588045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis.
    Tazawa R; Hamano E; Arai T; Ohta H; Ishimoto O; Uchida K; Watanabe M; Saito J; Takeshita M; Hirabayashi Y; Ishige I; Eishi Y; Hagiwara K; Ebina M; Inoue Y; Nakata K; Nukiwa T
    Am J Respir Crit Care Med; 2005 May; 171(10):1142-9. PubMed ID: 15735059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuated hematopoietic response to granulocyte-macrophage colony-stimulating factor in patients with acquired pulmonary alveolar proteinosis.
    Seymour JF; Begley CG; Dirksen U; Presneill JJ; Nicola NA; Moore PE; Schoch OD; van Asperen P; Roth B; Burdach S; Dunn AR
    Blood; 1998 Oct; 92(8):2657-67. PubMed ID: 9763547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effect of subcutaneous injection of low dose recombinant human granulocyte-macrophage colony-stimulating factor on pulmonary alveolar proteinosis.
    Zhang F; Weng D; Su Y; Yin C; Shen L; Zhang Y; Zhou Y; Li Q; Hu Y; Li H
    Respir Res; 2020 Jan; 21(1):1. PubMed ID: 31898493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of anti-GM-CSF antibodies in idiopathic pulmonary alveolar proteinosis.
    Lin FC; Chang GD; Chern MS; Chen YC; Chang SC
    Thorax; 2006 Jun; 61(6):528-34. PubMed ID: 16517574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct evidence that GM-CSF inhalation improves lung clearance in pulmonary alveolar proteinosis.
    Ohashi K; Sato A; Takada T; Arai T; Nei T; Kasahara Y; Motoi N; Hojo M; Urano S; Ishii H; Yokoba M; Eda R; Nakayama H; Nasuhara Y; Tsuchihashi Y; Kaneko C; Kanazawa H; Ebina M; Yamaguchi E; Kirchner J; Inoue Y; Nakata K; Tazawa R
    Respir Med; 2012 Feb; 106(2):284-93. PubMed ID: 22112784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autoantibody against granulocyte-macrophage colony-stimulating factor and other serum markers in pulmonary alveolar proteinosis].
    Xu KF; Chen Y; Guo ZJ; Zhu YJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):824-8. PubMed ID: 15730782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of granulocyte-macrophage colony-stimulating factor in patients with pulmonary alveolar proteinosis.
    Carraway MS; Ghio AJ; Carter JD; Piantadosi CA
    Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1294-9. PubMed ID: 10764326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis.
    Venkateshiah SB; Yan TD; Bonfield TL; Thomassen MJ; Meziane M; Czich C; Kavuru MS
    Chest; 2006 Jul; 130(1):227-37. PubMed ID: 16840407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis.
    Tazawa R; Trapnell BC; Inoue Y; Arai T; Takada T; Nasuhara Y; Hizawa N; Kasahara Y; Tatsumi K; Hojo M; Ishii H; Yokoba M; Tanaka N; Yamaguchi E; Eda R; Tsuchihashi Y; Morimoto K; Akira M; Terada M; Otsuka J; Ebina M; Kaneko C; Nukiwa T; Krischer JP; Akazawa K; Nakata K
    Am J Respir Crit Care Med; 2010 Jun; 181(12):1345-54. PubMed ID: 20167854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combination therapy of whole lung lavage and GM-CSF inhalation in pulmonary alveolar proteinosis.
    Yamamoto H; Yamaguchi E; Agata H; Kandatsu N; Komatsu T; Kawai S; Baba K; Awaya T; Nishikomori R; Tsurusawa M; Nakata K
    Pediatr Pulmonol; 2008 Aug; 43(8):828-30. PubMed ID: 18618617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of anti-GM-CSF antibody concentration, surfactant protein A and B levels, and serum LDH to pulmonary parameters and response to GM-CSF therapy in patients with idiopathic alveolar proteinosis.
    Seymour JF; Doyle IR; Nakata K; Presneill JJ; Schoch OD; Hamano E; Uchida K; Fisher R; Dunn AR
    Thorax; 2003 Mar; 58(3):252-7. PubMed ID: 12612307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Patient with autoimmune alveolar proteinosis who did not respond to GM-CSF inhalation therapy and underwent repeated whole-lung lavage].
    Ueda Y; Matsuo K; Tsushima M; Mizuta M; Fujiwara K; Yonei T; Sato T
    Nihon Kokyuki Gakkai Zasshi; 2009 Sep; 47(9):833-8. PubMed ID: 19827590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.